MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2025 International Congress

    The Phenotypic Spectrum of ATP1A3-Related Disorders: A Brazilian Cohort

    V. Procaci, A. Gomes, R. Hora, P. Lima, J. Ferrer, D. Maia, F. Cardoso, H. Linden, M. Krueger, E. Leão, T. Tonholo Silva, P. Nóbrega, O. Barsottini, J. Pedroso (São Paulo, Brazil)

    Objective: To describe a case series of patients with ATP1A3 variants, analyzing their phenotypic presentation and genetic characteristics in Brazil. Background: ATP1A3-related disorders exhibit a complex…
  • 2025 International Congress

    Arginase2 – a potential mediator in the pathology of the stratum

    M. Nalepa, K. Synoradzki, A. Skweres, A. Owczarek, M. Gewartowska, M. Wegrzynowicz (Warsaw, Poland)

    Objective: To investigate the effects of arginase 2 (Arg2) loss on the striatal mitochondria. Background: Arginase plays a role in the production of various metabolites…
  • 2025 International Congress

    Hypothalamic Atrophy in CANVAS/RFC1

    C. Lobo, V. Souza, T. Rezende, J. Neiva, P. Matos, F. Lima, A. Martinez, O. Barsottini, J. Pedroso, W. Marques Jr, M. França Jr (Campinas, SP, Brazil)

    Objective: We aimed to investigate hypothalamic volumetry in CANVAS/RFC1. Background: Cerebellar ataxia, neuropathy, and vestibular areflexia syndrome (CANVAS) is now recognized as a late-onset multisystem…
  • 2025 International Congress

    A Comprehensive Exploration of the Quality of Life and Caregiver Burden in Multiple System Atrophy

    I. Karagoz, H. Morris, H. Houlden, V. Chelban (London, United Kingdom)

    Objective: To evaluate the impact of MSA disease on QoL and caregiver burden and identify influencing factors of QoL in a large UK-based cohort Background:…
  • 2025 International Congress

    A VUS and the Value of a Biomarker in Ataxia with Oculomotor Apraxia Type 2

    F. Brito, A. Guerra, R. Kauark, G. Nunes, M. Vassoler, F. Nascimento, C. Nascimento, G. Piñeiro, . (Salvador, Brazil)

    Objective: Objective: To demonstrate the importance of serum biomarkers, such as alpha-fetoprotein (AFP), in the diagnostic evaluation of Ataxia with Oculomotor Apraxia Type 2 (AOA2).…
  • 2025 International Congress

    Phenotypic, Genotypic, Imaging and Neuropsychological Profile of Friedreich Ataxia

    R. Devaraj, R. Yadav, J. Saini, S. Hegde, M. Faruq, P. Pal (Bengaluru, India)

    Objective: 1. To characterise the phenotypic and genotypic spectrum of patients with Friedreich Ataxia2. To describe the imaging findings and to assess the neuropsychological profile…
  • 2025 International Congress

    Neurological manifestations and genotypes of Gaucher disease type 3: MDSGene systematic review

    S. Schaake, T. Usnich, J. Boehm, N. Steffen, N. Schell, C. Krüger, T. Gül-Demirkale, N. Bahr, T. Kleinz, H. Madoev, B. Laabs, Z. Gan-Or, R. Alcalay, C. Marras, K. Lohmann, C. Klein, M. Rossi (Luebeck, Germany)

    Objective: To characterize the spectrum of neurological manifestations of Gaucher disease type 3 (GD3) and identify the most common GBA1 variants. Background: Gaucher disease is…
  • 2025 International Congress

    Long-Term Safety and Efficacy of Valbenazine for Treating Huntington’s Disease Chorea

    E. Furr Stimming, E. Kayson, S. Karpuram, J. Goldstein, S. Hinton, O. Klepitskaya, H. Zhang, E. Dunayevich, D. Haubenberger (Houston, USA)

    Objective: To present safety and efficacy results from a long-term study of once-daily valbenazine for chorea associated with Huntington’s disease (HD). Background: In a 12-week…
  • 2025 International Congress

    Oculomotor Abnormalities in Spinocerebellar Ataxia Type-12: A Functional Neuroimaging Study

    P. Pankaj, A. Srivastava, S. Kumaran, A. Garg, R. Agarwal, M. Kumar, A. Sonakar, A. Nehra (New Delhi, India)

    Objective: This study aimed to investigate eye movements, specifically dysmetric saccades and cerebellar nystagmus, in Spinocerebellar Ataxia Type-12 (SCA12) using functional magnetic resonance imaging (fMRI)…
  • 2025 International Congress

    Quantifying ataxia in RFC1-related disorder using wearable devices

    J. Franco Neiva, C. Lobo Cardoso, I. Colombani, N. Serra Santos, F. Lima, P. Assis Matos, R. Paes Guimarães, A. Muro Martinez, J. Pedroso, O. Povoas Barsottini, M. França Jr, W. Marques Jr, T. Rezende (Campinas, Brazil)

    Objective: We aimed to compare standing balance and postural conditions between RFC1 patients and healthy controls. Background: RFC1-related ataxia is a progressive neurological disorder affecting…
  • « Previous Page
  • 1
  • …
  • 118
  • 119
  • 120
  • 121
  • 122
  • …
  • 1734
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley